RIL
VERA icon

Rothschild Investment LLC’s Vera Therapeutics VERA Stock Holding History

Rothschild Investment LLC’s Portfolio VERA Stock Details VERA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.98K Sell
116
-15
-11% -$559 ﹤0.01% 2262
2026
Q1 		$5.27K Buy
131
+31
+31% +$1.34K ﹤0.01% 2027
2025
Q4 		$5.06K Buy
100
+5
+5% +$178 ﹤0.01% 1872
2025
Q3 		$2.76K Sell
95
-15
-14% -$347 ﹤0.01% 2022
2025
Q2 		$2.59K Buy
110
+65
+144% +$1.46K ﹤0.01% 1883
2025
Q1 		$1.08K Sell
45
-10
-18% -$321 ﹤0.01% 2293
2024
Q4 		$2.33K Buy
55
+15
+38% +$664 ﹤0.01% 1721
2024
Q3 		$1.77K Buy
40
+25
+167% +$949 ﹤0.01% 1797
2024
Q2 		$543 Buy
15
+10
+200% +$397 ﹤0.01% 1961
2024
Q1 		$216 Buy
+5
New +$178 ﹤0.01% 1718

Other funds holding VERA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $1.93B AUM 134.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Rothschild Investment LLC's VERA Position: Q2 2026 in Review

Rothschild Investment LLC reduced its Vera Therapeutics (VERA) stake by 11% in Q2 2026, selling an estimated $559 and leaving 116 shares worth $4.98K. The position accounts for ﹤0.01% of the portfolio, ranked #2262.

Rothschild Investment LLC first reported a position in VERA in Q1 2024 and has held it in 10 quarters since. The position peaked at $5.27K in Q1 2026. 219 funds tracked by Wall St. Rank hold VERA as of Q2 2026.

  • Rothschild Investment LLC held 116 shares of Vera Therapeutics worth $4.98K as of Q2 2026.
  • Rothschild Investment LLC sold 15 Vera Therapeutics shares in Q2 2026, an estimated $559.
  • Vera Therapeutics made up ﹤0.01% of Rothschild Investment LLC's portfolio in Q2 2026, its #2262 holding.
  • Rothschild Investment LLC first reported a position in Vera Therapeutics in Q1 2024 and has held it in 10 quarters since.
  • Rothschild Investment LLC's Vera Therapeutics position peaked at $5.27K in Q1 2026.
  • 219 funds tracked by Wall St. Rank held Vera Therapeutics as of Q2 2026.

Based on Rothschild Investment LLC's 13F filing for Q2 2026, filed 6 Aug 2026.